ArticleOncology reports2023

Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines.

Monika Lukoseviciute et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.